Amgen India MD Naveen Gullapalli to speak at 14th LHIF on AI Disruption in Healthcare

The 14th edition of the Lifesciences & Healthcare Innovation Forum (LHIF), titled “AI Disrupt: Transforming Diagnosis, Discovery and Delivery”, is set to take place on April 16, 2025, at The Leela Palace, Bengaluru. Organized by the MeitY-NASSCOM Center of Excellence, the event will bring together healthcare leaders, innovators, and policymakers to explore AI’s transformative impact on the industry. 

Naveen Gullapalli, Managing Director of Amgen India, will be a key speaker at the forum. With deep expertise in healthcare and innovation, he will share insights on current trends and the future direction of AI in the sector.

Also Read: Reprosci conference: AI, XR and Simulation to revolutionise the future of healthcare

The conference will cover core focus areas including AI-led diagnosis, drug discovery through generative AI and real-world evidence, and enhanced patient care through AI-powered delivery systems. It will also spotlight themes such as AI-empowered medical devices, LLMs/VLMs for care access, and enterprise adoption use cases.

Attendees will witness innovation showcases by AI startups, keynotes from leaders like Mr. Tashi Gyalson and Dr. Sangeetha Reddy, and awards recognizing digital excellence. The event also includes a discussion on the DPDP Act from a healthcare lens.

With participation from leaders at Novo Nordisk, Siemens Healthineers, Baxter, and others, LHIF 2025 promises to be a defining moment in shaping AI’s role in the future of healthcare.